R&D

The R&D team was established in 2002 and covers all areas of product development from formulation sciences, analytical services, regulatory expertise and support services. The facilities are spread over an area of ~ 57000 Sq ft. The team has an enviable track record of successful development of generic medicines, high-barrier products and complex generics.

Capabilities:

  • Formulation development - a team of 50 highly qualified Formulation Scientists with expertise in development of wide range of dosage forms
    • Tablets, Capsules, ER/SR/CR/MR/DR formulations, EVT Tablets, Pellets, Controlled release pellets 
    • Parenterals (Lyophilised & Liquid), Solutions, Suspensions, Emulsions 
    • Topicals (Ointments/creams/eye drops) 
    • New Drug delivery systems (Oral and parenteral) 
    • Excellent capabilities in Development of Cytotoxic & Potent drugs 
    • Handling Special Delivery Systems & Complex Manufacturing processes
    • Scale up in Class 100,000 pilot manufacturing area

  • Analytical Development - a team of 180 experienced analyts with expertise in:
    • API characterisation 
    • Analytical Method Development & Validation 
    • Dissolution Profiling 
    • Impurity Profiling 
    • Stability Study (ICH & Custom Condition) 

The scientists are supported by 60 regulatory personnel with expertise in dossier compilation and additional regulatory procedures compliant to EMA, FDA, ANVISA and other regulatory agencies.

The R&D team developed numerous novel technologies, formulations and processes covered by 27 international patents.